ERBB2 and breast cancer: In line with CD24 expression using immunohistochemistry according to the subtypes of breast cancer, CD24 is highly expressed in luminal and HER2 subtypes of breast cancer cells, whereas low cell membrane expression was detected in MDA-MD–231 cells.